Aparato digestivo

2021

1. A Liquid Biopsy Assay for Noninvasive Identification of Lymph Node Metastases in T1 Colorectal Cancer

   Gastroenterology, Vol. 161, Núm. 1, pp. 151-162.e1

2. Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD

   Frontiers in Medicine, Vol. 8

3. Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg)

   The American journal of gastroenterology, Vol. 116, Núm. 6, pp. 1220-1229

4. Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

   Journal of Clinical Investigation, Vol. 131, Núm. 23

5. Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region

   International Journal of Infectious Diseases, Vol. 110, pp. 114-122

6. Analysis of post‐colonoscopy colorectal cancer and its subtypes in a screening programme

   Cancers, Vol. 13, Núm. 20

7. Antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013–2020: Results of the european registry on h. pylori management (hp-eureg)

   Antibiotics, Vol. 10, Núm. 9

8. BJS commission on surgery and perioperative care post-COVID-19

   British Journal of Surgery, Vol. 108, Núm. 10, pp. 1162-1180

9. COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology

   United European Gastroenterology Journal, Vol. 9, Núm. 7, pp. 750-765

10. Clinical Characteristics and Outcome of Drug-Induced Liver Injury in the Older Patients: From the Young-Old to the Oldest-Old

    Clinical Pharmacology and Therapeutics, Vol. 109, Núm. 4, pp. 1147-1158

11. Clinical correlates of anti-SARS-CoV-2 antibody profiles in Spanish COVID-19 patients from a high incidence region

    Scientific Reports, Vol. 11, Núm. 1

12. Clinical features, therapeutic requirements and evolution of patients with Crohn’s disease and upper gastrointestinal involvement (CROHNEX study)

    Alimentary Pharmacology and Therapeutics, Vol. 54, Núm. 8, pp. 1041-1051

13. Clinical outcome after anti-tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long-term study

    Alimentary pharmacology & therapeutics, Vol. 53, Núm. 12, pp. 1277-1288

14. Clinical practice guidelines. v spanish consensus conference on helicobacter pylori infection treatment

    Revista Espanola de Enfermedades Digestivas, Vol. 113, Núm. 10, pp. 740-763

15. Clinical, molecular and genetic characteristics of early onset gastric cancer: Analysis of a large multicenter study

    Cancers, Vol. 13, Núm. 13

16. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry

    Journal of Hepatology, Vol. 75, Núm. 1, pp. 86-97

17. Could protein content of urinary extracellular vesicles be useful to detect cirrhosis in alcoholic liver disease?

    International Journal of Biological Sciences, Vol. 17, Núm. 8, pp. 1864-1877

18. DRESS syndrome and drug-induced liver injury owing to antituberculous treatment

    Gastroenterologia y Hepatologia, Vol. 44, Núm. 6, pp. 427-428

19. Deep learning models for colorectal polyps

    Information (Switzerland), Vol. 12, Núm. 6

20. Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH

    Medicina Clinica, Vol. 156, Núm. 9, pp. 463.e1-463.e30